Abstract: The present disclosure discloses a capacitor structure and its formation method and a memory. The method includes: providing a substrate; forming an electrode support structure on the substrate in a stacking fashion, wherein the electrode support structure includes at least a first support layer on its top, a capacitor hole is formed at intervals within the electrode support structure and extends upwards in a direction perpendicular to a surface of the substrate; forming, within the capacitor hole, an electrode post and an electrode layer extending from the electrode post to the upper surface of the first support layer; removing the electrode layer; removing the first support layer; forming a dielectric layer on the top of the electrode support structure, wherein the dielectric layer covers the top of the electrode post, and an outer peripheral wall of the top of the electrode post is connected with the dielectric layer.

Abstract: Provided is a black matrix structure. The black matrix structure includes a plurality of black matrix strips that are intersected with each other, wherein a width the black matrix strip ranges from 2 to 2.5 microns, and a distance between any two adjacent black matrix strips in the plurality of black matrix strips ranges from 4 to 5 microns.

Abstract: The present application provides a preparation method for a core-shell structured tungsten/gadolinium oxide functional fiber for X and ? ray protection, comprising: first preparing a core-shell structured tungsten/gadolinium oxide powder; preparing a W@Gd2O3/PP blended melt from the powder; and preparing a W@Gd2O3/PP composite fiber from the blended melt. The core-shell structured tungsten/gadolinium oxide functional fiber prepared by the method can play a role in synergistic protection in the aspect of radiation protection, eliminate a weak protection area, and effectively absorb secondary radiation generated by radiation. Secondly, the prepared functional fiber has the characteristics of no lead and light weight, and has good application prospects in the aspect of X and ? ray radiation protection.

Abstract: Embodiments are disclosed for a compensating circuit for a boost circuit that outputs a voltage that is a function of a voltage signal. In one or more examples, the compensation circuit may include a gain that is adjustable in proportion to voltage output of the boost circuit and inversely proportionate to input current to the boost circuit.

Abstract: Provided are a drive compensation method and system of a display panel and a display device. The drive compensation method includes: determining at least one of the impedance and capacitive reactance variation curve of a first signal line in a column direction and determining the charge rate variation curve of first pixel units in a row direction; determining the compensation coefficients for a respective pixel unit in the column direction and/or the row direction according to the impedance and capacitive reactance variation curve of the first signal line in the column direction and/or the charge rate variation curve of first pixel units in the row direction; and compensating the compensation coefficients for the respective pixel unit in the column direction and/or the row direction to the drive signal of the respective pixel unit to drive the respective pixel unit.

Abstract: A catalyst for continuous production of 1,1,1,3-tetrachloropropane through gas-solid reaction as well as a preparation method and use thereof are provided. The catalyst includes a zero-valent iron and phosphorus co-modified carbon material which includes a carbon material as a carrier, a zero-valent iron supported onto the carrier and serving as an active component, and a phosphate functional group formed on the surface of the carbon material. The preparation method includes: co-modifying a carbon material using a ferric salt and organic phosphorus to obtain the catalyst for continuous production of 1,1,1,3-tetrachloropropane through gas-solid reaction. The present application further provides a method for continuous production of 1,1,1,3-tetrachloropropane through gas-solid reaction.

Abstract: An L-shaped metal mesh door and a manufacturing method thereof are provided. The metal mesh door includes an L-shaped metal mesh and a strip-shaped metal engagement slot. Two metal engagement slots are connected at a corner through L-shaped metal members inserted into a cavity of the metal engagement slot. The metal mesh is embedded in the metal engagement slot. The manufacturing method includes following steps. Manufacturing the metal mesh material by folding a metal mesh material into a 90° L shape. Manufacturing the metal engagement slot chamfering the two metal engagement slots by 45° at the corner, assembling the metal engagement slots through the L-shaped metal members inserted into the square cavity, and then fixing them with screws. Embedding the metal mesh fixedly in the engaging opening of the metal engagement slot, and filling a plastic soft strip in the circular cavity for fixing.

Abstract: A door type of kitchen cabinet includes a door panel and an edge-sealing handle mounted on an upper end of the door panel. The edge-sealing handle includes an edge-sealing plate located above a top portion of the door panel, a buckle plate disposed above a front end of the edge-sealing plate, a decorative plate disposed below the front end of the edge-sealing plate, a closing strip disposed at a bottom portion of the decorative plate, and a fixing leg disposed under a middle section of the edge-sealing plate and embedded in the top portion of the door panel. The top portion of the door panel is provided with a mounting groove corresponding to the fixing leg.

Abstract: The present disclosure provides display panel and display device. The display panel includes: a plurality of sub-pixel units defined by the plurality of data lines intersecting the plurality of scanning lines in an insulation manner. The plurality of sub-pixel units constitutes a plurality of rendering pixel units arranged in an array. Each of the plurality of rendering pixel units includes at least two adjacent sub-pixel units in a row of sub-pixel units, and a number of sub-pixel units included in each of the plurality of rendering pixel units is smaller than a total number of colors corresponding to color resists in the display panel. In each row of sub-pixel units, at least two rendering pixel units of the plurality of rendering pixel units are disposed between two adjacent touch lines. In each column of rendering pixel units, each rendering pixel unit performs color rendering with its adjacent sub-pixel unit.

Abstract: The invention relates to compounds of structural formulas (I) and (XVI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, Z, L, L2, R1, R2, R3, R21, n, q, and t are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Abstract: The invention relates to compounds of structural formula (I): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein Y, L, X1, X2, Z, R3, R4, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Abstract: The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included.

Abstract: Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

Abstract: The invention relates to compounds of structural formulas (I), (VII) and (XI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, X3, Y, Z, L, R1, R2, R3, R18 and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Abstract: Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

Abstract: Disclosed are bis(thio-hydrazide amide) disalts and pharmaceutical compositions thereof. Also disclosed are methods of using bis(thio-hydrazide amide) disalts to treat cancer.

Abstract: The invention relates to compounds of structural formulas (I), (VII) and (XI): or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X1, X2, X3, Y, Z, L, R1, R2, R3, R18 and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.